Nonetheless, in both melanoma models the ratio of pro-inflammatory CD4+ T helper cells to Tregs was increased, implying that in vivo cDC1 reprogramming drives a potent CD4+ T cell response. The gene discussed is MPPE1; the disease is melanoma.